Waer M |
New immunosuppressive agents for organ transplantation. |
1997 |
Acta Clin Belg |
pmid:9351290
|
Liang J et al. |
Refined structure of the FKBP12-rapamycin-FRB ternary complex at 2.2 A resolution. |
1999 |
Acta Crystallogr. D Biol. Crystallogr. |
pmid:10089303
|
Bracher A et al. |
Structural characterization of the PPIase domain of FKBP51, a cochaperone of human Hsp90. |
2011 |
Acta Crystallogr. D Biol. Crystallogr. |
pmid:21636895
|
Li P et al. |
Structure of the N-terminal domain of human FKBP52. |
2003 |
Acta Crystallogr. D Biol. Crystallogr. |
pmid:12499534
|
Schreier MH |
Immunophilins and immunosuppression by cyclosporins and macrolide structures. |
1994 |
Acta Derm Venereol Suppl (Stockh) |
pmid:7521103
|
Jungersted JM et al. |
Effects of topical corticosteroid and tacrolimus on ceramides and irritancy to sodium lauryl sulphate in healthy skin. |
2011 |
Acta Derm. Venereol. |
pmid:21365172
|
Laeijendecker R et al. |
A comparison of treatment of oral lichen planus with topical tacrolimus and triamcinolone acetonide ointment. |
2006 |
Acta Derm. Venereol. |
pmid:16710580
|
Granlund H et al. |
Treatment of lichenified atopic eczema with tacrolimus ointment. |
2001 Aug-Sep |
Acta Derm. Venereol. |
pmid:11720192
|
Hao D et al. |
Lymphocytic infiltration of the eyelid: two cases responding to tacrolimus and topical glucocorticoid. |
2013 |
Acta Derm. Venereol. |
pmid:23423497
|
Seo SR et al. |
Disrupted Skin Barrier is Associated with Burning Sensation after Topical Tacrolimus Application in Atopic Dermatitis. |
2017 |
Acta Derm. Venereol. |
pmid:28512670
|
Mandelin J et al. |
One-year treatment with 0.1% tacrolimus ointment versus a corticosteroid regimen in adults with moderate to severe atopic dermatitis: A randomized, double-blind, comparative trial. |
2010 |
Acta Derm. Venereol. |
pmid:20169301
|
Weisshaar E |
Successful treatment of genital pruritus using topical immunomodulators as a single therapy in multi-morbid patients. |
2008 |
Acta Derm. Venereol. |
pmid:18311464
|
Inoue T et al. |
Prolonged topical application of tacrolimus inhibits immediate hypersensitivity reactions by reducing degranulation of mast cells. |
2006 |
Acta Derm. Venereol. |
pmid:16585982
|
Ortonne JP et al. |
0.3% Tacrolimus gel and 0.5% Tacrolimus cream show efficacy in mild to moderate plaque psoriasis: Results of a randomized, open-label, observer-blinded study. |
2006 |
Acta Derm. Venereol. |
pmid:16585986
|
Tzung TY et al. |
Pimecrolimus and narrowband UVB as monotherapy or combination therapy in children and adolescents with atopic dermatitis. |
2006 |
Acta Derm. Venereol. |
pmid:16585987
|
Pitarch G et al. |
Systemic absorption of topical tacrolimus in Pyoderma gangrenosum. |
2006 |
Acta Derm. Venereol. |
pmid:16585995
|
Kirsner RS et al. |
Safety and efficacy of tacrolimus ointment versus pimecrolimus cream in the treatment of patients with atopic dermatitis previously treated with corticosteroids. |
2010 |
Acta Derm. Venereol. |
pmid:20107727
|
Fukamachi S et al. |
Therapeutic effectiveness of various treatments for eosinophilic pustular folliculitis. |
2009 |
Acta Derm. Venereol. |
pmid:19326000
|
Hartmann A et al. |
Occlusive treatment enhances efficacy of tacrolimus 0.1% ointment in adult patients with vitiligo: results of a placebo-controlled 12-month prospective study. |
2008 |
Acta Derm. Venereol. |
pmid:18779885
|
Ambo M |
Relapsing Kaposi's varicelliform eruption and herpes simplex following facial tacrolimus treatment for atopic dermatitis. |
2002 |
Acta Derm. Venereol. |
pmid:12353724
|